Skip to content

Treatment of Stress Urinary Incontinence Via Smartphone

Treatment of Stress Urinary Incontinence Via Smartphone

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01848938
Enrollment
123
Registered
2013-05-08
Start date
2013-03-31
Completion date
2014-11-30
Last updated
2017-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Stress Urinary Incontinence

Keywords

female, stress urinary incontinence, treatment, pelvic floor muscle training, smartphone, internet, life style, eHealth

Brief summary

The purpose of this study is to determine whether treatment of stress urinary incontinence (SUI) via smartphone is effective.

Detailed description

Female urinary incontinence (UI) is very common and affects up to one fourth of grownup women. It may reduce quality of life for those affected and costs for society are high. The most common type of urinary incontinence is SUI, i.e leakage when coughing, sneezing or jumping. The recommended first line treatment is pelvic floor muscle training (PFMT)which leads to improvement or cure in two-thirds of patients. In addition, life style changes, such as weight loss when obese, smoking cessation and reduction of fluid intake if high is recommended. There is a need for new , flexible and easily accessible treatment programmes for female urinary incontinence. In our previous study, we compared two treatment programmes for SUI without face-to-face contact: one internet based and one sent by post, both based on three months of PFMT. In this randomized controlled trial of 250 women aged 18-70 years, we found highly significant improvements (p\<0.001) with large effect sizes (\>0,8)concerning primary outcomes (symptoms and quality of life scores) but no significant differences between groups. Compared with the postal group, more participants in the internet group perceived they were much or very much improved (40.9% vs 26.5%, p\<0.01, reported reduced usage of incontinence aids (59.5% vs 41.4%, p=0.02) and were satisfied with the treatment programme (84.8% vs 62.9%, p\<0.001). The selling of smartphones is increasing rapidly. About 75% of all cellphones sold in Sweden today are smartphones. Two million adults in Sweden have a smartphone. Many smartphone owners have at least one health app on their phone. Exercise, diet, and weight apps are the most popular types. From our previous experience of an Internet-based programme, we have developed a treatment program designed for smartphone. The effect of the treatment programme will be evaluated after three months by comparing the effect in the smartphone group with the effect in the waiting group. Participants are consecutively recruited through our website. They answer an online screening survey with automated immediated response for initial screening of eligibility criteria. Informed consent and leakage diary (number of episodes of urinary leakage during 48 hours) are sent by post. After that, they answer a web questionnaire and finally they are interviewed by a researcher to confirm the diagnosis SUI and to ascertain that the patient is well informed of the study procedure. Women are then randomized to either of the two groups. Women in the smartphone group get a smartphone application for iphone or android. Follow-up after three months with a web questionnaire and a leakage diary. After that the waiting group get their smartphone application. We aim to recruit 120 women aged 18 and older via our website www.tät.nu. In the power calculation we assume that the improvement in the symptom score (ICIQ UI SF) and the QOL score (ICIQ luts QOL)in the smartphone group will be similar to the improvement we found in the postal group in our previous study. We also assume that the waiting group will improve in some extent. To detect a difference between groups, power 80%, 2-side test and significance 0,05, group size as follow ICIQ UI SF Smartphone group improves 2.9 (SD3,1) and waiting group 1,0 (SD2,0); 30 in each group ICIQ luts QOL Smartphone group improves 4.6 (SD6,7) and waiting group 2.0(SD3.0), 35 in each group PGI (patient´s global impression of improvement). 26,5% improves much or very much (smartphone) and 4% (waiting group):39 in each group We expect a drop out rate of 33% and thus need approximately 120 persons, 60 in each group.

Interventions

BEHAVIORALSmartphone treatment with PFMT

A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. The treatment period is three months

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stress urinary incontinence * leakage once a week or more often * duration of symptoms for at least 6 months * motivation and time to perform a 12 week long treatment with pelvic floor muscle training * ability to read and write Swedish * asset to smartphone * possibility to send and receive email and asset to printer * accept to be randomized to one of two groups; a treatment group or a waiting list group

Exclusion criteria

* participation in our previous internet study * pregnancy * former incontinence surgery * known malignancy in lower abdomen * difficulties with passing urine * visual blood in urine * intermenstrual bleeding * severe psychiatric diagnosis * neurological disease with affection on sensibility in legs or lower abdomen * urge incontinence

Design outcomes

Primary

MeasureTime frameDescription
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)baseline, three monthsThree items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)baseline, three monthsThe instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.

Secondary

MeasureTime frameDescription
Usage of Incontinence Aidsthree monthsUsage of incontinence aids during the last 4 weeks.
Patient Satisfactionthree monthsA self-rated question about if the current treatment was sufficient, with three response options
Incontinence Episode Frequency (IEF)baseline, three monthsnumber of incontinence episodes per week
Patient's Global Impression of Improvement Scale (PGI-I)three monthsA self-rated question that asks about the change experienced after treatment with 7 response options, ranging from very much better to very much worse.

Countries

Sweden

Participant flow

Recruitment details

We recruited community-dwelling women, from March 2013 to October 2014, through our website. Interested women filled out a questionnaire to determine whether they met the study criteria. Eligible women received a letter with informed consent and a 2-day leakage diary, and after returning this they also answered a web-based questionnaire.

Pre-assignment details

Randomisation was performed by concealing the allocations in sequentially numbered, opaque, sealed envelopes. An independent administrator generated the allocation sequence and prepared 130 envelopes. The study coordinator opened one envelope for each participant and assigned an e-mail, with materials for the corresponding study group.

Participants by arm

ArmCount
Smartphone Treatment
Smartphone treatment with pelvic floor muscle training (PFMT). Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
62
Waiting List
Waiting list for three months. They receive the smartphone application after follow-up.
61
Total123

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up11

Baseline characteristics

CharacteristicSmartphone TreatmentWaiting ListTotal
Age, Continuous44.8 years
STANDARD_DEVIATION 9.7
44.7 years
STANDARD_DEVIATION 9.1
44.7 years
STANDARD_DEVIATION 9.4
Body Mass Index24.0 kg/m^2
STANDARD_DEVIATION 4.1
24.5 kg/m^2
STANDARD_DEVIATION 4.4
24.2 kg/m^2
STANDARD_DEVIATION 4.2
Education
<3 years at university level
10 participants15 participants25 participants
Education
>=3 years at university level
52 participants46 participants98 participants
Parity
not nulliparous
57 participants57 participants114 participants
Parity
nulliparous
5 participants4 participants9 participants
Region of Enrollment
Sweden
62 Participants61 Participants123 Participants
Regular Medication
no regular medication
34 participants37 participants71 participants
Regular Medication
on regular medication
28 participants24 participants52 participants
Sex: Female, Male
Female
62 Participants61 Participants123 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Smoking
non-smoker
60 participants58 participants118 participants
Smoking
smoker
2 participants3 participants5 participants
Usage of incontinence aids
1-3 times/week
19 participants18 participants37 participants
Usage of incontinence aids
1 aid a day
9 participants10 participants19 participants
Usage of incontinence aids
>3 times/week, but not daily
11 participants5 participants16 participants
Usage of incontinence aids
Less than once a week
13 participants14 participants27 participants
Usage of incontinence aids
More than 1 aid a day
4 participants4 participants8 participants
Usage of incontinence aids
No use
6 participants10 participants16 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 620 / 61
serious
Total, serious adverse events
0 / 620 / 61

Outcome results

Primary

International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)

The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.

Time frame: baseline, three months

Population: intention-to-treat analysis

ArmMeasureGroupValue (MEAN)Dispersion
Smartphone TreatmentInternational Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)baseline34.1 units on a scaleStandard Deviation 6.1
Smartphone TreatmentInternational Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)3 month follow-up28.8 units on a scaleStandard Deviation 6.4
Waiting ListInternational Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)baseline34.8 units on a scaleStandard Deviation 6.1
Waiting ListInternational Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)3 month follow-up34.1 units on a scaleStandard Deviation 6.7
Comparison: analysis between groupsp-value: 0.005Linear Mixed Models analysis
Primary

International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)

Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity

Time frame: baseline, three months

Population: intention-to-treat analysis

ArmMeasureGroupValue (MEAN)Dispersion
Smartphone TreatmentInternational Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)baseline11.1 units on a scaleStandard Deviation 3
Smartphone TreatmentInternational Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)3 month follow-up7.0 units on a scaleStandard Deviation 3.5
Waiting ListInternational Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)baseline11.0 units on a scaleStandard Deviation 2.6
Waiting ListInternational Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)3 month follow-up10.2 units on a scaleStandard Deviation 3.2
Comparison: analysis between groupsp-value: <0.001Linear Mixed Models analysis
Secondary

Incontinence Episode Frequency (IEF)

number of incontinence episodes per week

Time frame: baseline, three months

Population: intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).

ArmMeasureGroupValue (MEDIAN)
Smartphone TreatmentIncontinence Episode Frequency (IEF)baseline21.0 episodes per week
Smartphone TreatmentIncontinence Episode Frequency (IEF)three month follow-up7 episodes per week
Waiting ListIncontinence Episode Frequency (IEF)baseline17.5 episodes per week
Waiting ListIncontinence Episode Frequency (IEF)three month follow-up14 episodes per week
Comparison: analysis between groupsp-value: 0.001Wilcoxon (Mann-Whitney)
Secondary

Patient Satisfaction

A self-rated question about if the current treatment was sufficient, with three response options

Time frame: three months

Population: Data for this outcome measure could only be collected for the smartphone treatment group.

ArmMeasureGroupValue (NUMBER)
Smartphone TreatmentPatient SatisfactionYes, I am completely free of leakage5 participants
Smartphone TreatmentPatient SatisfactionYes, sufficient, although I am not completely free35 participants
Smartphone TreatmentPatient SatisfactionNo20 participants
Secondary

Patient's Global Impression of Improvement Scale (PGI-I)

A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from very much better to very much worse.

Time frame: three months

Population: intention-to-treat analysis. Missing values at follow-up were replaced with a neutral value (i.e., no change).

ArmMeasureGroupValue (NUMBER)
Smartphone TreatmentPatient's Global Impression of Improvement Scale (PGI-I)a little better22 participants
Smartphone TreatmentPatient's Global Impression of Improvement Scale (PGI-I)a little worse0 participants
Smartphone TreatmentPatient's Global Impression of Improvement Scale (PGI-I)much better28 participants
Smartphone TreatmentPatient's Global Impression of Improvement Scale (PGI-I)much worse0 participants
Smartphone TreatmentPatient's Global Impression of Improvement Scale (PGI-I)no change5 participants
Smartphone TreatmentPatient's Global Impression of Improvement Scale (PGI-I)very much worse0 participants
Smartphone TreatmentPatient's Global Impression of Improvement Scale (PGI-I)very much better6 participants
Waiting ListPatient's Global Impression of Improvement Scale (PGI-I)very much worse0 participants
Waiting ListPatient's Global Impression of Improvement Scale (PGI-I)very much better0 participants
Waiting ListPatient's Global Impression of Improvement Scale (PGI-I)much better3 participants
Waiting ListPatient's Global Impression of Improvement Scale (PGI-I)a little better9 participants
Waiting ListPatient's Global Impression of Improvement Scale (PGI-I)no change42 participants
Waiting ListPatient's Global Impression of Improvement Scale (PGI-I)a little worse6 participants
Waiting ListPatient's Global Impression of Improvement Scale (PGI-I)much worse0 participants
Comparison: analysis between groupsp-value: <0.001Wilcoxon (Mann-Whitney)
Secondary

Usage of Incontinence Aids

Usage of incontinence aids during the last 4 weeks.

Time frame: three months

Population: intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).

ArmMeasureGroupValue (NUMBER)
Smartphone TreatmentUsage of Incontinence Aids>3 times/week, but not daily5 participants
Smartphone TreatmentUsage of Incontinence AidsNo use23 participants
Smartphone TreatmentUsage of Incontinence AidsLess than once a week13 participants
Smartphone TreatmentUsage of Incontinence Aids1-3 times/week10 participants
Smartphone TreatmentUsage of Incontinence Aids1 aid a day8 participants
Smartphone TreatmentUsage of Incontinence AidsMore than 1 aid a day2 participants
Waiting ListUsage of Incontinence Aids1 aid a day12 participants
Waiting ListUsage of Incontinence Aids>3 times/week, but not daily4 participants
Waiting ListUsage of Incontinence Aids1-3 times/week13 participants
Waiting ListUsage of Incontinence AidsNo use14 participants
Waiting ListUsage of Incontinence AidsMore than 1 aid a day6 participants
Waiting ListUsage of Incontinence AidsLess than once a week11 participants
Comparison: analysis between groupsp-value: 0.023Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026